Written question asked by Alison Thewliss (Scottish National Party) on Monday, 8 March 2021, in the House of Commons. It was due for an answer on Thursday, 11 March 2021 (named day). It was answered by Steve Barclay (Conservative) on Thursday, 11 March 2021 on behalf of the Treasury.
Thalidomide
- Question
-
To ask the Chancellor of the Exchequer, what the Barnett Consquentials are for (a) Scotland, (b) Wales and (c) Northern Ireland of his Budget 2021 announcement on funding for the Thalidomide Health Grant Renewal.
- Answer
-
At Budget 2021 a lifetime commitment was announced to continue the Thalidomide Health Grant in England once the existing funding commitment expires in 2023-24.
The devolved administrations have already received Barnett consequentials in the usual way for any funding provided to the Department of Health and Social Care at previous fiscal events and spending reviews up to 2021-22.
For 2022-23 onwards, the devolved administrations will receive funding through the Barnett formula at the upcoming spending review and future fiscal events. The government is committed to engaging closely with them to ensure all recipients benefit from this funding.
Secondary information
- Type
- Written question
- Reference
- 164514
- Session
- 2019-21
- Related items
- Subjects
- Devolution Finance Thalidomide
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-04-21 12:41:19 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/164514
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/164514
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/164514